|
|
||||||||
Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87185
| |
ABSTRACT |
|---|
|
|
|---|
Interleukin-6 (IL-6) and tumor necrosis factor-
(TNF-
)
have been implicated as key mediators in inflammation, morbidity, and
mortality associated with sepsis. We examined the role of IL-6 and
TNF-
signaling on hypothermia, fever, cachexia, anorexia, and
survival during sepsis induced by cecal ligation and puncture (CLP) in
male and female gene knockout mice. Male wild-type mice developed an
initial hypothermia and subsequent fever during sepsis. Male IL-6
knockout mice did not develop fever; rather, they maintained a profound
hypothermia during sepsis. Male TNF p55/p75 receptor (TNFR) knockout
mice had attenuated hypothermia, but developed a virtually identical
fever as wild-type mice. Cachexia did not differ between male wild-type
and IL-6 or TNFR knockout mice, whereas anorexia was prolonged in IL-6
knockout mice. Due to the rapid lethality of sepsis in female mice,
survival was the only variable we were able to statistically compare
among female genotypes. Female wild-type mice had significantly
decreased survival compared with male wild-type mice. Survival was
significantly enhanced in male and female TNFR knockout mice compared
with their wild-type controls. Lack of IL-6 did not affect male or
female lethality. These data support the hypothesis that IL-6 is a key
mediator of fever and food intake, whereas TNF is responsible for the
initial hypothermia and lethality of sepsis in both sexes of mice. The enhanced lethality of CLP-treated female mice supports a role for sex
steroids during sepsis.
acute phase response; fever; hypothermia; anorexia; cecal ligation and puncture
| |
INTRODUCTION |
|---|
|
|
|---|
THE SEPSIS SYNDROME is characterized by such
pathophysiological changes as hypotension, hypothermia [i.e.,
core body temperature (Tb) < 36.5°C] or fever (i.e., core
Tb > 38.5°C), metabolic
acidosis, pulmonary hemorrhage, and death within several minutes to
hours (4). Several lines of evidence support the hypothesis that interleukin-6 (IL-6) and tumor necrosis factor-
(TNF-
) play a
role in the sepsis syndrome. First, administration of IL-6 or TNF-
into several species induces an acute phase response (APR) that
consists of sepsislike symptoms (3, 6, 21, 26, 30). Second, high
circulating concentrations of IL-6 and TNF-
have been measured
during endotoxic shock in several species and are negatively correlated
with survival (5, 7, 19, 22). Third, a protective effect of inhibition
of IL-6 and TNF-
on sepsis lethality has been demonstrated (15, 28).
However, the protective effect of cytokine neutralization is highly
influenced by the time course of antibody administration, the species,
and the experimental model of sepsis, making the therapeutic efficacy difficult to assess (21, 28).
Fever is a common APR to infection. In response to systemic
inflammation induced by the injection of a high, septiclike dose of
bacterial lipopolysaccharide (LPS), mice develop an APR that is
accompanied by such sickness symptoms as hypothermia, fever, cachexia
(i.e., decreased body weight), and anorexia (i.e., decreased food
intake) (12, 14). Considerable data support the hypothesis that
LPS-induced fever is mediated by IL-6 and TNF-
. IL-6 is thought to
act as an endogenous pyrogen and TNF-
as an endogenous antipyretic
or cryogen. For example, Chai et al. (6) observed an absence of fever
in response to the injection of LPS into mice deficient in IL-6. On the
other hand, we have shown that mice deficient in TNF p55 (type I) and
p75 (type II) receptors (i.e., the two known signaling receptors for
TNF) developed exacerbated fevers to the peripheral injection of a high
dose of LPS (14). In addition, Kozak et al. (12) reported attenuated
hypothermia in Swiss-Webster mice following coinjection of the soluble
TNF receptor or neutralizing antiserum to TNF-
with a high dose of LPS.
Gender differences in the development of fever and the incidence and lethality of sepsis have been reported. Murakami and Ono (20) showed that female rats developed a diminished febrile response to the same dose of LPS injected into male rats. Female rats showed a diminished maximum temperature as well as a different time course to the peak of the fever. Alternatively, Morimoto et al. (17) induced hypothermia in female rats using a dose of intravenously injected LPS that induced fever in male rats. Kozak et al. (13) showed differences in the febrile response of male and female mice to a subcutaneous injection of turpentine. Interestingly, female mice developed larger fevers than males in response to turpentine. These data suggest to us that gender differences in the development of fever are dependent on the inflammatory stimulus. Zellweger et al. (32) showed a higher rate of sepsis survival in female than male mice after cecal ligation and puncture (CLP). A higher occurrence and mortality of male patients with sepsis has also been reported (16). It is unclear whether these studies underestimate the frequency of sepsis in females or whether females are more tolerant to sepsis.
Although injections of LPS or live endotoxin are reasonable models of
infection, CLP more closely simulates the clinical situation of a
perforated necrotic bowel, inducing several pathophysiological changes
observed during a bacterial infection of mixed intestinal flora origin.
Many studies have been performed on the role of IL-6 and TNF-
in
thermoregulation and lethality, using the peripheral injection of LPS
or gram-negative bacteria as a sepsis model. However, these studies
used neutralizing cytokine antibodies whose effects are dependent on
diffusion and the time course of injection, thus potentially resulting
in limited neutralization of the biological action of IL-6 and TNF-
.
Gene knockout mice, on the other hand, provide a unique research tool
to investigate the role of cytokines and cytokine receptors in the APR
to inflammation due to the elimination of the cytokine's action in all
tissues of the body. The present study was designed to examine the
thermoregulatory, cachectic, and anorectic responses and lethality to
CLP using IL-6 and TNF p55/p75 receptor (TNFR) knockout mice. These
mice lack functional genes for IL-6 or TNF p55 and p75 receptors,
respectively, in all tissues of the body. Using these mice, we tested
the hypothesis that an absence of IL-6 and TNF-
signaling would
result in altered sickness symptoms (i.e., hypothermia, fever,
cachexia, and anorexia) and survival in gene knockout mice compared
with their wild-type controls after CLP. Due to discrepancies in the
literature regarding the role of gender in fever and sepsis lethality,
we also examined differences in our measured responses between male and
female wild-type and gene knockout mice.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Experimental animals. Adult
specific-pathogen-free C57Bl/6 × 129J
F2 hybrid male and female mice
weighing 25-30 g were obtained from Jackson Laboratories (Bar
Harbor, ME) to serve as wild-type controls for all experiments. All
IL-6 and TNFR knockout mice were age- and sex-matched C57Bl/6 × 129J random hybrids bred and raised in a facility approved by the
American Association for Accreditation of Laboratory Animal Care. IL-6
knockout breeder mice were generously provided by Dr. Valeria Poli
(Instituto di Ricerche Molecolare IRBM P. Angeletti, Rome, Italy).
These mice do not produce IL-6 in response to a peripheral injection of
LPS (24). TNFR breeder mice were kindly provided by Dr. Jacques Peschon
(Immunex Research, Seattle, WA). Both lymphoid and myeloid lineage
cells from these mice fail to bind TNF-
(23). During all
experimentation, mice were individually housed in plastic cages at 30 ± 1°C ambient temperature and maintained on a 12:12-h light-dark cycle with lights on at 0600. Rodent laboratory chow (Teklad
Rodent Diet W8604) and drinking water were provided ad libitum.
Body temperature. Core Tb (±0.1°C) was continuously monitored using the Dataquest III system (Mini-Mitter, Sunriver, OR), as described elsewhere (14). Briefly, each animal was anesthetized with halothane, and a miniature battery-operated, temperature-sensitive transmitter (model VMFH) was implanted intra-abdominally. The frequency of the signal emitted by the transmitter is proportional to the animal's Tb. The signal was received by an antenna underneath each animal's cage and transferred to a peripheral processor connected to an IBM-PC that processed the frequency signals into temperatures using predetermined calibration values. All Tb measurements were collected at 5-min intervals in conscious, unrestrained animals and graphically presented as 1-h averages. All transmitters were calibrated before implantation and at the completion of all experiments to ensure validity of Tb measurements. Data from any transmitter that did not recalibrate to within ±0.1°C of the preimplantation value were excluded from data analysis.
Body weight and food intake measurements. Body weight and food intake were measured on a top-loading balance with accuracy to ±0.1 g. All measurements were made between 0900 and 1000. Each cage was checked for possible food spillage, and measurements were corrected accordingly. Changes in body weight and food intake were calculated by subtracting the value obtained at each successive 24-h period after CLP or sham surgery from the value obtained immediately before surgery. Therefore, all changes in body weight and food consumption are relative to pre-experimentation values. Any animal observed to be losing weight before the day of CLP or sham surgery was excluded from experimentation.
CLP protocol. CLP was performed
1 wk
after transmitter implantation to ensure recovery of circadian rhythms
in Tb, normal body weight, and
food consumption before experimentation. Mice were anesthetized with
halothane, and their abdomens were shaved and swabbed with Betadine and
alcohol. An ~1-cm incision was made through the skin and abdominal
muscles lateral to the midline (to avoid the site of the previous
incision made during transmitter implantation). The cecum was isolated
and ligated with 3-0 silk (Ethicon, Somerville, NJ) below the
ileocecal valve to prevent bowel obstruction. The cecum was then
punctured once with an 18-gauge needle and gently squeezed to express
the cecal contents through the wound. The cecum was replaced into the
peritoneal cavity, and the peritoneal wall and skin were closed with
interrupted sutures. In sham-operated mice, the cecum was exposed and
replaced into the peritoneal cavity without ligation or puncture. No
fluid resuscitation or antibiotics were given after CLP or sham
surgery. For all mice, the skin incision was dressed with a topical
antibiotic (0.2% Nitrofurazone; Durvet, Blue Springs, MO), and the
animals were returned to their home cages for recovery with free access to food and water. All CLP and sham surgeries were performed between 0900 and 1030, immediately after measurement of body weight and food
intake.
Survival. Each animal was monitored twice daily for survival due to the potentially rapid lethality of the experimental procedure. Any animal that appeared moribund or unresponsive to external stimuli was killed to avoid undue pain and suffering. The survival time of each mouse was recorded every 12 h and analyzed for statistical significance with respect to genotype and experimental manipulation. Thus survival data are presented for each 12-h period following surgery.
Experimental design. For all experiments, we used four groups of mice: wild-type sham, wild-type CLP, knockout sham, and knockout CLP. In some mice, transmitter batteries died, so Tb measurements were not recorded following CLP or sham surgery. However, body weight, food intake, and survival were still recorded in all mice through night 8 postsurgery. Therefore, differences exist in the sample sizes listed for individual APR measurements in Figs. 1-8.
Statistical analysis. Results are presented as means ± SE. Survival data are presented as a percentage. To test for statistically significant differences among groups in patterns of Tb and changes in body weight and food consumption, ANOVA with repeated measures followed by post hoc Scheffé's test was performed. Survival curves were analyzed by log-rank analysis using the Savage test and the Wilcoxon test. We used both statistical tests to analyze the survival curves as a whole, because these tests weight the late or early survival times, respectively. A P value of <0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Tb responses of male wild-type and IL-6 knockout mice after CLP. Before experimentation, wild-type and IL-6 knockout mice had similar circadian rhythms in Tb, with low daytime and high nighttime values (data not shown).
Tb measurements are shown only through 44-h post-CLP because all mice survived sepsis during this time period. We did not detect any statistically significant correlation between final survival status and 44-h Tb measurements.
Figure 1 depicts 1-h averages of Tb for male wild-type and IL-6 knockout mice. Immediately after surgery, all groups showed a virtually identical hypothermic effect of surgical anesthesia (0-1 h). By 2 h, sham-operated wild-type and IL-6 knockout mice had recovered their circadian rhythm in Tb, with virtually no difference between groups. CLP-treated mice were hypothermic compared with their sham-treated controls from 2 to 15 h post-CLP (P < 0.05), with virtually no differences between wild-type and IL-6 knockout mice.
|
Starting at 15 h after CLP, Tb in wild-type mice began to increase; the next day they developed fever that was significantly elevated above Tb of their sham-operated controls by 26 h (P < 0.05). This febrile response of the wild-type mice was maintained throughout the daytime hours (26-32 h, P < 0.05). Due to the nighttime circadian rise in Tb of the sham-operated mice, the fever in response to CLP did not reach statistical significance from 33 to 44 h. IL-6 knockout mice did not develop a fever in response to CLP. Rather, IL-6 knockout mice subjected to CLP were significantly hypothermic compared with their sham-operated controls at several time points (2-21 h and 33-44 h, P < 0.05). This hypothermic effect of CLP treatment in the IL-6 knockout mice did not reach statistical significance from 22 to 32 h the day after surgery due to the low daytime circadian Tb of the sham-operated mice. The profound differences in the Tb responses of the CLP-treated wild-type and IL-6 knockout mice (i.e., fever vs. hypothermia, respectively) resulted in significant differences between these groups from 15 to 44 h (P < 0.05). The transient increase in Tb seen in all groups of mice at 24 h represents a stress-induced elevation due to weighing procedures.
Induction of cachexia and anorexia in male wild-type and IL-6 knockout mice by CLP. Figure 2A depicts the changes in body weight (i.e., cachexia) of sham and CLP-treated wild-type and IL-6 knockout mice. Sham surgery did not affect changes in body weight of wild-type and IL-6 knockout mice on day 1, whereas on day 2 there was a small but significant difference between groups (Fig. 2A; P < 0.05). Wild-type and IL-6 knockout mice showed a significant cachectic response to CLP on days 1 and 2, compared with their sham-operated controls (Fig. 2A; P < 0.05). Wild-type and IL-6 knockout mice did not differ on any day with respect to their cachectic response to CLP.
|
Changes in food intake (i.e., anorexia) of sham and CLP-operated wild-type and IL-6 knockout mice are depicted in Fig. 2B. Sham surgery did not significantly affect the daily change in food intake of wild-type or IL-6 knockout mice on any day. Therefore, the decrease in body weight seen in the sham-operated wild-type mice on day 2 was not due to a reduction in food intake (compare open circles in Fig. 2, A and B). In response to CLP, wild-type and IL-6 knockout mice displayed anorexia compared with their sham controls on days 1 and 2 (P < 0.05). A direct comparison of CLP-operated wild-type and IL-6 knockout mice revealed a significant difference between groups on day 2 only (P < 0.05); that is, CLP-operated wild-type mice began to increase their food intake on this day.
Survival status of male wild-type and IL-6 knockout mice after CLP. Figure 3 shows the percent survival of male wild-type and IL-6 knockout mice for each 12-h period after CLP. All sham-operated mice survived the entire time course of the experiment (data not shown). Using log-rank analysis, we did not detect a significant difference in survival between male wild-type mice and IL-6 knockout mice during sepsis (Savage test P = 0.18; Wilcoxon test P = 0.44; Fig. 3).
|
APR of female wild-type and IL-6 knockout mice after CLP. Due to the short-term survival of female mice in response to CLP (most mice only survived 12 h; see Fig. 4), we could not statistically compare daily changes in Tb or cachectic or anorectic responses of female mice. However, we did assess 12-h changes in survival (see below).
|
Survival status of female wild-type and IL-6 knockout mice after CLP. Figure 4 depicts the 12-h changes in survival of female wild-type and IL-6 knockout mice after CLP. All sham-operated mice survived the entire time course of the experiment (data not shown). A direct comparison using log-rank analysis of the survival times of female wild-type and knockout mice revealed no significant differences between groups during any 12-h time period (Savage test P = 0.71; Wilcoxon test P = 0.70; Fig. 4).
Tb of male wild-type and TNFR knockout mice after CLP. Male wild-type and TNFR knockout mice did not differ with respect to their circadian rhythms in Tb before experimentation. All mice demonstrated normal low daytime and high nighttime Tb values (data not shown).
Tb measurements are shown only through 44-h post-CLP because all mice survived sepsis during this time period. We did not detect any statistically significant correlation between final survival status and 44-h Tb measurements.
Figure 5 depicts 1-h averages of Tb for male wild-type and TNFR knockout mice. All groups showed a virtually identical hypothermic effect of anesthesia from 0 to 1 h. By 2 h, sham-treated mice resumed their circadian rhythm in Tb, with virtually no differences between groups (Fig. 5). In response to CLP, wild-type mice developed a profound hypothermia compared with their sham-treated controls from 2 to 21 h (P < 0.05), followed by a fever from 26 to 31 h (P < 0.05). In contrast, CLP-operated TNFR knockout mice were significantly hypothermic compared with their sham-operated controls from 3 to 9 h only (P < 0.05). From 18 to 31 h and 39 to 44 h, TNFR knockout mice developed fever following CLP that was significantly elevated above the Tb of their sham-operated knockout controls (P < 0.05). A direct comparison of these Tb changes in the wild-type and knockout mice revealed a significant difference from 4 to 23 h (P < 0.05). That is, a lack of TNF signaling resulted in a significantly attenuated hypothermia and earlier febrile response to CLP compared with wild-type mice. However, the febrile response of the CLP-treated wild-type and knockout mice was virtually identical from 26 to 31 h and 39 to 44 h (P > 0.05). The transient increase in Tb seen in all groups of mice at 24 h postsurgery represents a stress-induced elevation due to weighing procedures.
|
Induction of cachexia and anorexia in male wild-type and TNFR knockout mice by CLP. Changes in body weight of male wild-type and TNFR knockout mice after CLP or sham treatment are shown in Fig. 6A. Sham surgery did not affect the 24-h changes in body weight of male wild-type and knockout mice. CLP induced a significant cachectic response in wild-type and TNFR knockout mice on days 1 and 2, with virtually no difference between groups on either day.
|
Figure 6B shows the changes in food intake of male wild-type and TNFR knockout mice. Sham surgery did not affect the 24-h changes in food intake. CLP-treatment resulted in virtually identical anorectic responses in wild-type and TNFR knockout mice on days 1 and 2 (P < 0.05). On day 1, TNFR knockout mice showed a tendency toward a blunted anorectic response compared with their CLP-operated wild-type controls (Fisher, P < 0.05).
Survival status of male wild-type and TNFR knockout mice after CLP. Figure 7 shows 12-h changes in survival of male wild-type and TNFR knockout mice after CLP. All sham-operated mice survived the entire time course of the experiment (data not shown). TNFR knockout mice had significantly enhanced survival in response to CLP compared with their wild-type counterparts (Savage test P = 0.02; Wilcoxon test P = 0.02; Fig. 7). A direct comparison between the CLP-treated male wild-type mice used as controls for the IL-6 knockout mice (Fig. 3) and those used with the TNFR knockout mice (Fig. 7) shows 30 vs. 70% final survival. Using log-rank analysis to compare the curves as a whole, we did not detect any statistically significant difference between the two male wild-type groups (Savage P = 0.13; Wilcoxon P = 0.14).
|
APR of female wild-type and TNFR knockout mice after CLP. Due to the short-term survival of female wild-type mice in response to CLP (most mice only survived 12 h; see Fig. 8), we could not statistically compare daily changes in Tb or cachectic or anorectic responses of female wild-type and TNFR knockout mice. However, we did assess 12-h changes in survival (see below)
|
Survival status of female wild-type and TNFR knockout mice after CLP. Figure 8 depicts the 12-h changes in survival of female wild-type and TNFR knockout mice after CLP. All sham-operated mice survived the entire time course of the experiment (data not shown). As was seen with the male TNFR knockout mice, the absence of TNF signaling resulted in a significantly enhanced survival of the female knockout mice compared with their wild-type counterparts (Savage test P = 0.001; Wilcoxon test P = 0.0013; Fig. 8).
| |
DISCUSSION |
|---|
|
|
|---|
The results of the present study demonstrate that sepsis induces a
complex APR in mice, consisting of hypothermia, fever, cachexia,
anorexia, and lethality. We used male and female gene knockout mice to
examine the role of endogenous IL-6 and TNF-
signaling on these
responses. IL-6 knockout mice developed hypothermia, but not fever,
during sepsis, whereas TNFR knockout mice developed fever, but minimal
hypothermia. These data indicate that during sepsis in mice IL-6
functions as an endogenous pyrogen, whereas TNF-
functions as an
endogenous antipyretic. On the other hand, cachexia was unaffected and
anorexia only transiently affected by a lack of IL-6 or TNF-
signaling, supporting a role for other, perhaps redundant, cytokine
mechanisms in the control of these responses. Interestingly, female
wild-type and knockout mice succumbed to the lethality of sepsis sooner
than males, such that 24-h changes in
Tb, cachexia, and anorexia could
not be assessed. The reason for these gender differences is unclear but
supports a role for sex steroids in the ability of the host to recover
from a septic insult. Interestingly, these data contradict earlier
reports of female mice in proestrus showing more tolerance to sepsis
(CLP) than their male counterparts (32). In the present study,
lethality during sepsis was also significantly decreased due to a lack
of TNF signaling, but not IL-6, in female and male mice. These data are
in contrast to previous reports of both TNF and IL-6 antagonism having
a protective effect on sepsis lethality (15, 28). This disparity may
result from the different methodologies used (i.e., pharmacological
antagonism vs. gene knockout studies).
Wild-type mice developed an initial hypothermia and a subsequent fever during the 44-h time period after CLP (Figs. 1 and 5). Mice deficient in IL-6 developed the initial hypothermia but did not develop fever. These data support the hypothesis that IL-6 mediates fever, but not hypothermia, during sepsis in mice. CLP induces an intra-abdominal infection of gram-negative and gram-positive bacterial origin, and a pyrogenic role for IL-6 has been implicated using other bacterial models of fever. For example, it has been shown in mice that neutralization of IL-6 activity abrogates fever in response to the peripheral injection of LPS (6). However, in the present study IL-6 knockout mice did not simply resume their circadian variation in Tb as a consequence of the abrogated fever. Instead, these mice developed a pronounced hypothermia that persisted throughout the 44-h observation period after CLP. These data suggest to us that a lack of IL-6 signaling results in the release of an endogenous cryogen in these mice that attenuates the normal circadian rise in Tb.
Considerable data indicate that a number of endogenously produced
factors have antipyretic properties in vivo. These include such factors
as
-melanocyte-stimulating hormone (27), glucocorticoids (18), and
TNF-
(12, 14). Although TNF-
is often considered an endogenous
pyrogen, data in the literature support the interpretation that under
certain circumstances TNF-
acts as an endogenous antipyretic or
cryogen. For example, Alexander et al. (2) reported attenuated hypothermia in rats treated with recombinant TNF-
(and thus made tolerant to the cytokine's actions) before CLP. Similarly, Kozak et
al. (12) reported attenuated hypothermia in mice treated with the
soluble TNF receptor or neutralizing TNF-
antiserum before the
injection of a high, septiclike dose of LPS. Furthermore, we recently
reported exacerbation of the early phase of the febrile response to LPS
injected peripherally in TNFR knockout mice (14). All of these studies
suggest that the endogenous action of TNF-
and its p55 and p75
receptors is cryogenic.
In the present study, we extended our earlier observations of a
cryogenic action of endogenous TNF-
signaling using CLP as a model
of sepsis. We report here that the initial hypothermia, but not the
subsequent fever, in response to CLP was attenuated in TNFR knockout
mice. These data are in contrast to the report by Remick et al. (25)
indicating that neutralizing TNF-
antiserum did not affect
hypothermia induced by LPS or CLP in CD-1 mice. Perhaps these
discrepancies represent the effect of partial neutralization of TNF-
using antiserum (25) versus total neutralization of TNF-
action in
the receptor knockout mice (present study). Alternately, a strain
difference may explain these different results.
IL-6 inhibits endotoxin-induced production of TNF-
. Aderka et al.
(1) demonstrated an inhibition of LPS-induced TNF-
release by IL-6
both in vitro and in vivo. In a study by Fattori et al. (9), serum
TNF-
induction by LPS was found to be approximately threefold higher
in IL-6 knockout mice compared with their wild-type controls.
Similarly, van der Poll et al. (31) measured enhanced plasma and organ
(i.e., liver) levels of TNF-
in C57Bl/6 mice treated with an
anti-IL-6 monoclonal antibody (MAb) before CLP. TNF-
levels were
similar in control and MAb-treated mice at 2, 6, and 12 h post-CLP.
These time points correspond to the virtually identical hypothermic
responses seen in the wild-type and IL-6 knockout mice used in the
present study. However, in the study by van der Poll et al. (31),
plasma TNF-
levels were exacerbated at 24 h after anti-IL-6 MAb
treatment, a time point that corresponds to observed differences in the
thermoregulatory responses of CLP-treated wild-type and IL-6 knockout
mice used in the present study (i.e., when IL-6 knockout mice were
hypothermic and wild-type mice were febrile; see Fig. 1).
Unfortunately, plasma and peritoneal levels of TNF-
in septic
wild-type and anti-IL-6 MAb-treated mice were not reported between 12 and 24 h or beyond 24 h in the study by van der Poll et al. (31). In
any case, on the basis of these data, we speculate that the lack of
IL-6 in the knockout mice resulted in the exacerbated release of
TNF-
and its cryogenic activity such that
Tb was significantly lower in
these mice during sepsis. Studies are currently ongoing to assess
plasma levels of TNF-
at several time points after CLP in the IL-6
knockout mice.
In addition to changes in Tb,
common phenomena associated with bacterial infection include cachexia
and anorexia or hypophagia. Wild-type mice did not differ from IL-6 or
TNFR knockout mice with respect to their cachectic responses. Similar
results were reported by Fattori et al. (9), in which LPS injection
into IL-6 knockout mice produced cachexia and anorexia similar to that observed in wild-type mice. These data suggest that IL-6 and TNF-
signaling are not required for these host defense responses to CLP and
may indicate the development of cytokine redundancy in vivo. Cytokine
interactions in vivo may play an important role in infection-induced
APR such that the absence of one cytokine throughout development (i.e.,
as in the knockout mice) may be compensated for by another. Other
investigators have reported the ability of antibodies against IL-6 to
partially block LPS-induced weight loss (29).
Interestingly, despite the lack of a difference in the cachectic
responses of male wild-type and IL-6 knockout mice treated with CLP, we
did detect a significant difference in their anorectic responses on
day 2 (Fig.
2B). That is, male wild-type mice
had a significant attenuation of anorexia on day
2, whereas IL-6 knockout mice showed a similar degree
of anorexia as seen on day 1. Although these data suggest that IL-6 may be involved in the recovery of food
intake after CLP, we are cautious in our interpretation of these data
because we did not monitor changes in this variable beyond the 48 h
after surgery. Thus the long-term effects of an absence of IL-6 or
TNF-
signaling on the cachectic and anorectic responses cannot be
elucidated in the present study and require further characterization.
Although TNFR knockout mice showed a tendency toward a more pronounced
anorectic response to CLP than wild-type mice, this difference only
reached statistical significance using the less conservative post hoc
Fisher's test. We have monitored changes in body weight and food
intake in wild-type and TNFR knockout mice for up to 6 days after the
injection of a high dose of LPS and found no difference between groups,
again indicating the possibility of cytokine redundancies in these mice
(14).
Survival data in the current study support a role for TNF-
and IL-6
interactions in the lethality of sepsis. TNF inhibitors have been shown
to protect against sepsis lethality (15). Male and female TNFR knockout
mice showed prolonged survival in response to CLP compared with their
wild-type controls. On the basis of these data, we conclude that
TNF-
contributes significantly to lethality during sepsis. A direct
effect of high plasma TNF-
levels on the lethality of sepsis has
been similarly reported in studies that demonstrate a protective effect
of IL-10 treatment. IL-10 is a pleiotropic cytokine that blocks the in
vitro production of TNF-
, as well as other cytokines, by
LPS-activated monocytes/macrophages (8). Howard et al. (11) showed a
protective effect of IL-10 treatment in endotoxemic mice that
correlated with a reduction in serum TNF-
levels. Interestingly,
mice injected with IL-10 before a high dose of LPS showed attenuated
hypothermia and lethality, responses that corresponded with reduced
plasma TNF-
levels (10). These data further support a role of
cytokine interactions in vivo and the importance of modulation of
TNF-
levels for the control of hypothermia and lethality of sepsis
in mice. Similarly, high serum levels of IL-6 have been correlated with
the severity and poor outcome of sepsis (5, 7, 22). The systemic
administration of IL-6 inhibitors has been demonstrated to protect mice
and rats against septic shock induced by the injection of gram-negative bacteria (15). However, in the present study, survival of the male and
female IL-6 knockout mice was similar, rather than enhanced, compared
with their wild-type controls. Similarly, van der Poll et al. (31)
found no effect of anti-IL-6 MAb treatment on survival of mice, despite
enhanced TNF-
levels in those mice at the 24-h time point after CLP.
The reason for discrepancies between the IL-6 knockout survival data
and previously published observations using IL-6 inhibitors is unclear.
Gender differences with respect to the lethality of CLP were also
evident in the present study. One of the main findings of this study
was that female mice were more susceptible to the lethality of CLP
compared with their male counterparts. In all of our experiments, we
found that female mice began to succumb to the lethality of CLP within
12 h, whereas male mice survived through 44 h. These data suggest that
sex steroids may play a pivotal role in susceptibility of the host to
sepsis, although an examination of the specific hormones responsible
for the gender differences in survival was beyond the scope of our
objectives. Interestingly, our data are in contrast to previous reports
in the literature of higher rates of sepsis mortality among males than
females. For example, Zellweger et al. (32) examined female mice in the
proestrus cycle and reported enhanced survival and reduced
immunosuppression compared with male mice after CLP. However, the use
of 12-h-fasted mice that were saline-resuscitated after CLP and the
different strain of mice used may account for the differences between
the survival data reported by Zellweger et al. (32) and our studies. It
is intriguing to note, however, that despite the rapid lethality rates
of the female mice used in the present study, the absence of TNF
signaling still proved beneficial to survival (Fig. 8), thus
implicating TNF-
as a critical cytokine in the lethality of sepsis,
regardless of gender. Clearly, additional studies are required to
determine the mechanisms responsible for the observed gender
differences in survival rates during sepsis.
In the past several years our laboratory has been actively involved in experimentation with several different types of knockout mice for the study of thermoregulatory processes. The use of genetically engineered mice in physiological studies of inflammatory responses circumvents the problems inherent with the injection of pharmacological agents. Certainly, the most significant contribution of this model to the study of fever (and related sickness behaviors) is the ability to study the effect of the elimination of a cytokine's action from all tissues of the body. However, there is a caveat to the knockout approach in that the generation of negative results, or the inability to confirm the results using a more traditional approach (i.e., antibody administration), suggests that redundancies may have developed that can mask the true function of the cytokine in vivo. Results obtained using knockout mice that contradict data obtained via "traditional" pharmacological means may be difficult to interpret because knockout mice have never been exposed to the cytokine's actions. Gene knockout mice may use compensatory mechanisms to elicit physiological and behavioral responses to an inflammatory insult that are indistinguishable from those seen in wild-type mice. Thus experiments using pharmacological and genetic approaches are both important in developing a greater understanding of the complex relationship between cytokines and the physiological responses they control.
Perspectives
Sepsis induces a wide variety of pathophysiological changes thought to be detrimental to survival of the host. IL-6 and TNF-
have been
implicated as key mediators of the sepsis syndrome. However, there has
been difficulty establishing a specific role for these cytokines in the
regulation of sickness behaviors during infection due to the complex
interaction of cytokines with overlapping biological activities.
Although use of the mouse model in the study of the APR during the
sepsis syndrome does not allow us to make a direct comparison to the
clinical condition of sepsis, we believe that the present study further
elucidates the role of IL-6 and TNF-
in several of the APR and the
lethality of this bacterial condition. Whereas our data provide
additional support for a pyrogenic role for IL-6 and an antipyretic
role for TNF-
in the febrile response to sepsis, our survival data
suggest more complex regulatory mechanisms are involved in sepsis
tolerance. It is clear that gender differences cited in the literature
for the control of fever and tolerance to sepsis need to be examined more thoroughly to reconcile the apparent controversies that exist between species and models of clinical drug intervention.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Valeria Poli for the generous supply of IL-6 knockout mice and Dr. Jacques Peschon and Moira Glaccum from the Immunex Research Corporation for their generous supply of TNF p55 and p75 receptor knockout mice. We also thank Dr. Margaret Menache for her invaluable assistance in the statistical evaluation of the survival data.
| |
FOOTNOTES |
|---|
This research was supported by National Institute of Allergy and Infectious Diseases Grant AI-27556.
Address for reprint requests: L. R. Leon, Diabetes Branch, NIDDK, NIH, Bldg. 10, Room 8N-252, 10 Center Dr. MSC 1770, Bethesda, MD 20892-1770.
Received 9 September 1997; accepted in final form 3 April 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aderka, D.,
L. Junming,
and
J. Vilcek.
IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.
J. Immunol.
143:
3517-3523,
1989[Abstract].
2.
Alexander, H. R.,
B. C. Sheppard,
J. C. Jensen,
H. N. Langstein,
C. M. Buresh,
D. Venzon,
E. C. Walker,
D. L. Fraker,
M. C. Stovroff,
and
J. A. Norton.
Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.
J. Clin. Invest.
88:
34-39,
1991.
3.
Bauss, F.,
W. Droge,
and
D. N. Mannel.
Tumor necrosis factor mediates endotoxic effects in mice.
Infect. Immun.
55:
1622-1625,
1987
4.
Bone, R. C.,
C. J. Fisher,
T. D. Clemmer,
G. J. Slotman,
C. A. Metz,
and
R. A. Balk.
Sepsis syndrome: a valid clinical entity.
Crit. Care Med.
17:
389-393,
1989[Medline].
5.
Casey, L. C.,
R. A. Balk,
and
R. C. Bone.
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.
Ann. Intern. Med.
119:
771-778,
1993
6.
Chai, Z.,
S. Gatti,
C. Toniatti,
V. Poli,
and
T. Bartfai.
Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1
: a study on IL-6-deficient mice.
J. Exp. Med.
183:
311-316,
1996
7.
Damas, P.,
D. Ledoux,
M. Nys,
Y. Vrindts,
D. de Groote,
P. Franchimont,
and
M. Lamy.
Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.
Ann. Surg.
215:
356-362,
1992[Medline].
8.
De Waal Malefyt, R.,
J. Abrams,
B. Bennett,
C. G. Figdor,
and
J. E. deVries.
Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
J. Exp. Med.
174:
1209-1220,
1991
9.
Fattori, E.,
M. Cappelletti,
P. Costa,
C. Sellitto,
L. Cantoni,
M. Carelli,
R. Faggioni,
G. Fantuzzi,
P. Ghezzi,
and
V. Poli.
Defective inflammatory response in interleukin 6-deficient mice.
J. Exp. Med.
180:
1243-1250,
1994
10.
Gerard, C.,
C. Bruyns,
A. Marchant,
D. Abramowicz,
P. Vandenabeele,
A. Delvaux,
W. Fiers,
M. Goldman,
and
T. Velu.
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
J. Exp. Med.
177:
547-550,
1993
11.
Howard, M.,
T. Muchamuel,
S. Andrade,
and
S. Menon.
Interleukin 10 protects mice from lethal endotoxemia.
J. Exp. Med.
177:
1205-1208,
1993
12.
Kozak, W.,
C. A. Conn,
J. J. Klir,
G. H. W. Wong,
and
M. J. Kluger.
TNF soluble receptor and antiserum against TNF enhance lipopolysaccharide fever in mice.
Am. J. Physiol.
269 (Regulatory Integrative Comp. Physiol. 38):
R23-R29,
1995
13.
Kozak, W.,
V. Poli,
D. Soszynski,
C. A. Conn,
L. R. Leon,
and
M. J. Kluger.
Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis.
Am. J. Physiol.
272 (Regulatory Integrative Comp. Physiol. 41):
R621-R630,
1997
14.
Leon, L. R.,
W. Kozak,
J. Peschon,
and
M. J. Kluger.
Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice.
Am. J. Physiol.
272 (Regulatory Integrative Comp. Physiol. 41):
R563-R569,
1997
15.
Lundblad, R.,
P. Ekstrom,
and
K.-E. Giercksky.
Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats.
Shock
3:
210-215,
1995[Medline].
16.
McGowan, J. E.,
M. W. Barnes,
and
N. Finland.
Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935-1972) with special reference to hospital-acquired cases.
J. Infect. Dis.
132:
316-335,
1975[Medline].
17.
Morimoto, A.,
T. Ono,
T. Watanabe,
and
N. Murakami.
Fever in rats during normal and dehydrated conditions.
J. Appl. Physiol.
61:
2060-2066,
1986
18.
Morrow, L. E.,
J. L. McClellan,
C. A. Conn,
and
M. J. Kluger.
Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide.
Am. J. Physiol.
264 (Regulatory Integrative Comp. Physiol. 33):
R1010-R1016,
1993
19.
Mozes, T.,
S. Ben-Efraim,
C. J. A. M. Tak,
J. P. C. Heiligers,
P. R. Saxena,
and
I. L. Bonta.
Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock.
Immunol. Lett.
27:
157-162,
1991[Medline].
20.
Murakami, N.,
and
T. Ono.
Sex-related differences in fever development of rats.
Am. J. Physiol.
252 (Regulatory Integrative Comp. Physiol. 21):
R284-R289,
1987
21.
O'Riordain, M. G.,
D. S. O'Riordain,
R. G. Molloy,
J. A. Mannick,
and
M. L. Rodrick.
Dosage and timing of anti-TNF-
antibody treatment determine its effect on resistance to sepsis after injury.
J. Surg. Res.
64:
95-101,
1996[Medline].
22.
Patel, R. T.,
K. I. Deen,
D. Youngs,
J. Warwick,
and
M. R. B. Keighley.
Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis.
Br. J. Surg.
81:
1306-1308,
1994[Medline].
23.
Peschon, J. J.,
D. S. Torrance,
K. L. Stocking,
M. B. Glaccum,
C. Otten,
C. R. Willis,
D. Charrier,
P. J. Morrissey,
C. B. Ware,
and
K. M. Mohler.
TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.
J. Immunol.
160:
943-952,
1998
24.
Poli, V.,
R. Balena,
E. Fettori,
A. Markatos,
M. Yamamoto,
H. Tanaka,
G. Ciliberto,
G. A. Rodan,
and
F. Constantini.
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
EMBO J.
13:
1189-1196,
1994[Medline].
25.
Remick, D.,
P. Manohar,
G. Bolgos,
J. Rodriguez,
L. Moldawer,
and
G. Wollenberg.
Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not lethality of cecal ligation and puncture.
Shock
4:
89-95,
1995[Medline].
26.
Schobitz, F.,
G. Pezeshki,
T. Pohl,
U. Hemmann,
P. C. Heinrich,
F. Holsboer,
and
J. M. H. M. Reul.
Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo.
FASEB J.
9:
659-664,
1995[Abstract].
27.
Shih, S. T.,
O. Khorram,
J. M. Lipton,
and
S. M. McCann.
Central administration of
-MSH antiserum augments fever in the rabbit.
Am. J. Physiol.
250 (Regulatory Integrative Comp. Physiol. 19):
R803-R806,
1986.
28.
Silva, A. T.,
K. F. Bayston,
and
J. Cohen.
Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-
in experimental gram-negative shock.
J. Infect. Dis.
162:
421-427,
1990[Medline].
29.
Strassman, G.,
M. Fong,
S. Windsor,
and
R. Neta.
The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo.
Cytokine
5:
285-290,
1993[Medline].
30.
Tracey, K. J.,
and
B. Beutler.
Shock and tissue injury induced by recombinant human cachectin.
Science
234:
470-473,
1986
31.
Van der Poll, T.,
C. V. Keogh,
D. Helfgott,
L. Berman,
W. A. Buurman,
and
S. F. Lowry.
Effects of anti-interleukin 6 on inflammatory responses during murine septic peritonitis.
J. Endotoxin Res.
3:
463-470,
1996.
32.
Zellweger, R.,
M. W. Wichmann,
A. Ayala,
S. Stein,
C. M. DeMaso,
and
I. H. Chaudry.
Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males.
Crit. Care Med.
25:
106-110,
1997[Medline].
This article has been cited by other articles:
![]() |
K. M. Nautiyal, H. McKellar, A.-J. Silverman, and R. Silver Mast cells are necessary for the hypothermic response to LPS-induced sepsis Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R595 - R602. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Wernstedt, A. Edgley, A. Berndtsson, J. Faldt, G. Bergstrom, V. Wallenius, and J.-O. Jansson Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R551 - R557. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vyas, P. Javadi, P. J. DiPasco, T. G. Buchman, R. S. Hotchkiss, and C. M. Coopersmith Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1048 - R1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Leon, D. A. DuBose, and C. W. Mason Heat stress induces a biphasic thermoregulatory response in mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R197 - R204. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. von Meyenburg, B. H. Hrupka, D. Arsenijevic, G. J. Schwartz, R. Landmann, and W. Langhans Role for CD14, TLR2, and TLR4 in bacterial product-induced anorexia Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R298 - R305. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Leon Molecular Biology of Thermoregulation: Invited Review: Cytokine regulation of fever: studies using gene knockout mice J Appl Physiol, June 1, 2002; 92(6): 2648 - 2655. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Kerr, J. J. Irvine, J. J. Search, N. A. Gingles, A. Kadioglu, P. W. Andrew, W. L. McPheat, C. G. Booth, and Tim. J. Mitchell Role of Inflammatory Mediators in Resistance and Susceptibility to Pneumococcal Infection Infect. Immun., March 1, 2002; 70(3): 1547 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tesfaigzi, K. Rudolph, M. J. Fischer, and C. A. Conn Bcl-2 mediates sex-specific differences in recovery of mice from LPS-induced signs of sickness independent of IL-6 J Appl Physiol, November 1, 2001; 91(5): 2182 - 2189. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wellmer, J. Gerber, J. Ragheb, G. Zysk, T. Kunst, A. Smirnov, W. Bruck, and R. Nau Effect of Deficiency of Tumor Necrosis Factor Alpha or Both of Its Receptors on Streptococcus pneumoniae Central Nervous System Infection and Peritonitis Infect. Immun., November 1, 2001; 69(11): 6881 - 6886. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, C. H. Fang, and P.-O. Hasselgren Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R1013 - R1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. McCullough, Y. Takahashi, T. Le, Q. J. Pittman, and M. G. Swain Attenuated febrile response to lipopolysaccharide in rats with biliary obstruction Am J Physiol Gastrointest Liver Physiol, July 1, 2000; 279(1): G172 - G177. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mizuno, Y. Kannan, M. Tokunaga, M. Moriyama, Y. Kiso, K. Kusakabe, J. Yamate, K. Kiyomiya, and T. Sugano Role of hypothermia induced by tumor necrosis factor on apoptosis and function of inflammatory neutrophils in mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R157 - R165. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Leon, W. Kozak, K. Rudolph, and M. J. Kluger An antipyretic role for interleukin-10 in LPS fever in mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R81 - R89. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |